Sandisk (SNDK) Pulls Back Before Earnings, Is The Upside Already Priced In?

Sandisk (SNDK) heads into its 5 August earnings report after pulling back from a June all time high, with investors weighing recent Micron results, AI driven demand and existing customer agreements.

See our latest analysis for Sandisk.

Sandisk’s recent pullback, including a 1 day share price decline of about 11% and a 1 month share price return down roughly 31%, comes after a powerful run that has left the year to date share price return above 400% and the 1 year total shareholder return extremely high. As a result, some traders appear to be reassessing AI related memory demand and earnings risk ahead of results.

If you are weighing Sandisk’s swings against other AI exposed opportunities, this is a useful moment to broaden your watchlist with 55 AI infrastructure stocks

After a one month slide that still leaves Sandisk up several times year to date, the question now is whether recent weakness has reset expectations enough, or whether most of the easy upside has already been claimed ahead of earnings.

Advertisement

Most Popular Narrative: 19% Undervalued

Against Sandisk’s last close of $1,436.56, the most followed narrative fair value of $1,772.91 points to meaningful upside, built on ambitious growth and margin assumptions.

The analysts have a consensus price target of $1772.91 for Sandisk based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $3250.0, and the most bearish reporting a price target of just $1000.0.

Read the complete narrative.

Want to see what really sits behind that gap in price targets? Revenue compounding hard, margins stepping up and a future earnings multiple that assumes serious staying power.

Result: Fair Value of $1,772.91 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Sandisk’s story can change quickly if today’s tight NAND supply swings back to oversupply, or if AI driven demand falls short of current expectations.

Find out about the key risks to this Sandisk narrative.

Another View on Sandisk’s Valuation

The analyst narrative frames Sandisk as about 19% undervalued using a fair value P/E of 24.5x. On current numbers though, the stock trades at a P/E of 47.2x versus 23.6x for the Global Tech industry and 46.7x for peers, with a fair ratio of 136.3x. That gap suggests plenty of potential upside, but also real valuation risk if expectations cool.

For a closer look at what this P/E gap might mean for Sandisk if markets shift closer to the fair ratio over time, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:SNDK P/E Ratio as at Jul 2026
NasdaqGS:SNDK P/E Ratio as at Jul 2026

Next Steps

With Sandisk’s valuation debate clearly split between risks and rewards, this is a good time to review the full picture yourself and move quickly to form your own stance by weighing the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Sandisk?

If Sandisk has you thinking about what else could deserve a place on your watchlist, do not sit on the sidelines while other opportunities pass you by.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:SNDK

Sandisk

Develops, manufactures, and sells data storage devices and solutions using NAND flash technology in the United States, Europe, the Middle East, Africa, Asia, and internationally.

Exceptional growth potential with flawless balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
AnimalDoctorKwon
CSBT.F logo
AnimalDoctorKwon on Kuros Biosciences ·

How a Mispriced Medtech Engine is Disrupting $5,000 Bone Graft Giants.

Fair Value:US$342.1892.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
RZLV logo
European_Hidden_Gem_Stocks on Rezolve AI ·

⚡ Two-Minute Drill: Rezolve AI - The AI That Doesn't Recommend Products. It Buys Them.

Fair Value:US$80.7897.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0